Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Safety differentiation: Emerging competitive edge in drug development

Uteng, Marianne and Urban, Laszlo and Brees, Dominique and Mueller, Patrick and Kullak-Ublick, Gerd-Achim and Tougas, Gervais and Bouchard, Page and Chibout, Salah-Dine (2018) Safety differentiation: Emerging competitive edge in drug development. Drug discovery today.

Abstract

With increasing expectations to provide evidence of drugs’ efficacy, safety and cost-effectiveness, best-in-class is a major value driver for the pharmaceutical industry. Superior safety is a key innovation and differentiation criterion leading to better risk/benefit profiles, safety margins and broader co-medication opportunities. Achieving best-in-class safety profile is a competitive process with significant uncertainty at early stage to be mitigated by novel non-clinical and clinical approaches. Strategic adjustments to a clinical outcome-focused development approach are required upon the continuously evolving risk/benefit profile of a drug candidate. Key success criteria include scientific expertise and effective decisions during the entire drug development process.

Item Type: Article
Date Deposited: 13 Oct 2018 00:45
Last Modified: 13 Oct 2018 00:45
URI: https://oak.novartis.com/id/eprint/36385

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.